Julian Hamfjord
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Elevated KRAS protein level is associated with better survival in pancreatic cancer.
Journal: BMC cancer
Published: April 27, 2025
Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends.
Journal: ESMO gastrointestinal oncology
Published: August 02, 2024
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: March 11, 2023
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis.
Journal: Therapeutic advances in medical oncology
Published: August 31, 2022
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: February 10, 2022
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.
Journal: British journal of cancer
Published: December 03, 2021
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: May 04, 2021
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer.
Journal: International journal of cancer
Published: December 02, 2020
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 03, 2019
Serum N-Glycome Characterization in Patients with Resectable Periampullary Adenocarcinoma.
Journal: Journal of proteome research
Published: October 31, 2015
Last Updated: 09/26/2026